Home › Trial NCT07038278
5-AminoLevulinic Acid Aided Resection Margins in Sarcoma
- Trial IDNCT07038278
- StatusNot Yet Recruiting
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorUniversity of Colorado, Denver
- Enrollment20
- Start date2026-09-01
- ConditionsSoft Tissue Sarcoma (STS)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.